5.63
price down icon4.25%   -0.25
after-market Dopo l'orario di chiusura: 5.65 0.02 +0.36%
loading
Precedente Chiudi:
$5.88
Aprire:
$5.67
Volume 24 ore:
1.47M
Relative Volume:
1.18
Capitalizzazione di mercato:
$305.58M
Reddito:
$1.02B
Utile/perdita netta:
$-757.20M
Rapporto P/E:
-0.3814
EPS:
-14.76
Flusso di cassa netto:
$-257.90M
1 W Prestazione:
-21.48%
1M Prestazione:
-14.70%
6M Prestazione:
-49.96%
1 anno Prestazione:
-46.74%
Intervallo 1D:
Value
$5.625
$5.9319
Intervallo di 1 settimana:
Value
$5.625
$7.355
Portata 52W:
Value
$4.02
$13.28

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
Nome
Emergent Biosolutions Inc
Name
Telefono
240-631-3200
Name
Indirizzo
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
Dipendente
900
Name
Cinguettio
@emergentbiosolu
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
EBS's Discussions on Twitter

Confronta EBS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
5.63 319.15M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.38 64.91B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.16 43.33B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.66 42.36B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.38 17.72B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
294.28 12.42B 2.99B 1.21B 1.13B 25.06

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-30 Iniziato H.C. Wainwright Buy
2024-08-22 Iniziato Rodman & Renshaw Buy
2024-03-07 Aggiornamento The Benchmark Company Hold → Buy
2023-11-20 Ripresa JP Morgan Underweight
2023-08-29 Downgrade The Benchmark Company Buy → Hold
2023-04-10 Aggiornamento The Benchmark Company Hold → Buy
2023-03-17 Downgrade JP Morgan Neutral → Underweight
2022-11-10 Downgrade The Benchmark Company Buy → Hold
2022-04-29 Downgrade Cantor Fitzgerald Overweight → Neutral
2022-01-20 Aggiornamento The Benchmark Company Hold → Buy
2021-11-08 Downgrade The Benchmark Company Buy → Hold
2021-05-05 Downgrade Argus Buy → Hold
2021-04-07 Iniziato The Benchmark Company Buy
2021-02-24 Aggiornamento Chardan Capital Markets Neutral → Buy
2021-02-19 Downgrade Chardan Capital Markets Buy → Neutral
2021-01-08 Downgrade Wells Fargo Overweight → Equal Weight
2020-09-14 Ripresa JP Morgan Neutral
2020-07-31 Reiterato Chardan Capital Markets Buy
2019-09-12 Iniziato Guggenheim Buy
2019-09-04 Aggiornamento Wells Fargo Market Perform → Outperform
2018-11-02 Aggiornamento Goldman Neutral → Buy
2018-08-03 Reiterato Chardan Capital Markets Buy
2018-06-13 Iniziato Argus Buy
2018-04-25 Downgrade Wells Fargo Outperform → Market Perform
2018-01-24 Iniziato Goldman Neutral
2018-01-16 Reiterato Chardan Capital Markets Buy
2016-06-28 Reiterato Singular Research Buy
2016-04-15 Iniziato Chardan Capital Markets Buy
2016-03-28 Iniziato Singular Research Buy
2016-02-19 Iniziato Wells Fargo Outperform
2014-05-15 Iniziato Summer Street Research Buy
2011-05-31 Reiterato WBB Securities Strong Buy
2011-01-10 Reiterato Wedbush Outperform
2010-11-05 Reiterato Wedbush Outperform
2010-08-18 Aggiornamento WBB Securities Buy → Strong Buy
2010-08-06 Reiterato Caris & Company Buy
Mostra tutto

Emergent Biosolutions Inc Borsa (EBS) Ultime notizie

pulisher
08:45 AM

Insider Sellers Might Regret Selling Emergent BioSolutions Shares at a Lower Price Than Current Market Value - simplywall.st

08:45 AM
pulisher
Jul 31, 2025

What catalysts could drive Emergent BioSolutions Inc. stock higher in 2025Chart Pattern Ideas For Fast Growth - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

What institutional investors are buying Emergent BioSolutions Inc. stockPost Market Outlook For Every Investor - jammulinksnews.com

Jul 30, 2025
pulisher
Jul 30, 2025

Why Emergent BioSolutions Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - beatles.ru

Jul 30, 2025
pulisher
Jul 29, 2025

Emergent BioSolutions Inc. Recovery Hinges on Volume BreakoutPotential Breakout Stock List Published This Week - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Investors Hope for Bounce in Emergent BioSolutions Inc. After SelloffAI Based High Gain Watchlist Scanner Shared - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Can Emergent BioSolutions Inc. Regain Momentum After BreakdownCapital Growth With Controlled Risk Picks Suggested - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-29 03:10:46 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Emergent BioSolutions (EBS) Applauds Naloxone Accessibility in U - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives - The Manila Times

Jul 28, 2025
pulisher
Jul 28, 2025

Emergent BioSolutions Publishes Review on Brincidofovir for Mpox Treatment in Expert Review of Anti-infective Therapy - Quiver Quantitative

Jul 28, 2025
pulisher
Jul 28, 2025

Is Emergent BioSolutions Inc. stock overvalued or undervaluedHigh-performance stocks for savvy investors - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

U.S. House Takes Historic Step: NARCAN Now Available in Every Building to Prevent Opioid Deaths - Stock Titan

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Emergent BioSolutions Inc. in the next 12 monthsFree Stock Selection - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Emergent BioSolutions Inc. as a “Buy”Invest smarter with advanced market data - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 04:58:37 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Emergent BioSolutions Inc. stock compared to the marketRecord-breaking gains - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Emergent BioSolutions Inc. stockInvest confidently with actionable market data - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Emergent BioSolutions Inc. company’s balance sheetMaximize returns with strategic stock selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Emergent BioSolutions Inc. stock priceTriple-digit profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Emergent BioSolutions Inc. stockExponential wealth increase - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Emergent BioSolutions Inc. a good long term investmentHigh-yield growth strategies - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 23, 2025

Emergent BioSolutions Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 20, 2025

Is MDU Resources Group Inc. a good long term investmentHigh-yield investments - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

AGYS Stock Analysis and ForecastAccelerated financial growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Hawthorn Bancshares Inc. Stock Analysis and ForecastBreakthrough capital growth - jammulinksnews.com

Jul 18, 2025

Emergent Biosolutions Inc Azioni (EBS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.57
price down icon 0.87%
$13.79
price up icon 0.80%
$8.81
price up icon 0.80%
drug_manufacturers_specialty_generic RDY
$13.94
price down icon 1.97%
$128.91
price up icon 0.53%
$294.28
price up icon 7.13%
Capitalizzazione:     |  Volume (24 ore):